The Integrated Institutes for Impact on Disease (IIID) is accredited by the National Association of Testing Authorities of Australia (NATA) in the Research and Development (R&D) program, to perform HLA sequence-based typing and viral sequencing in compliance with the ISO/AS 17025 standard for Laboratory testing.
The Institute is also accredited to perform sequence-based HLA typing in compliance to the standards of the American Society for Histocompatibility and Immunogenetics (ASHI). R&D accreditation demonstrates that the Institute has implemented good research management practices which provide collaborators with a high level of confidence in the validity and accuracy of results generated.
The Institute has in place a rigorous Quality Management System to ensure that laboratory testing accords with published standards. The Quality Management System at IIID is comprised of managerial and technical components to ensure that standards are met. These include ensuring that:
methods are validated and regularly reviewed
staff are trained in techniques and use of specialized equipment
equipment is calibrated
reagents are tested
samples are curated
data integrity is intact
Technical proficiency is regularly demonstrated by participation in external Quality Assurance Programs. Regular internal audits verify compliance to standards and identify opportunities for continuous improvement. For more information on Quality Assurance at the Institute, please contact the Executive Manager, Dr Paul Egan on (08) 9360 1367 or email@example.com